1-20 of 235
Ibrahim Yakoub Agha
Close
Sort by
Journal Articles

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

Esteban Arrieta-Bolaños, Lars L. J. van der Burg, Tobias Gedde-Dahl, Marie Robin, Urpu Salmenniemi, Nicolaus Kröger, Ibrahim Yakoub-Agha, Anne Huynh, Charles R Crawley, Eric Deconinick, Claude-Eric Bulabois, Edouard Forcade, Eleni Tholouli, Joost G. K. van der Hem, Peter van Balen, Jorinde Desiree Hoogenboom, Liesbeth C. de Wreede, Florent Malard, Annalisa Ruggeri, Katharina Fleischhauer
Journal: Blood
Blood blood.2024024351.
https://doi.org/10.1182/blood.2024024351
Published: 2024
Includes: Supplemental data
Journal Articles

Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Clinical Trials & Observations
Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, Urpu Salmenniemi, Johan Maertens, Jakob Passweg, Didier Blaise, Jennifer L. Byrne, Nicolaus Kröger, Katja Sockel, Patrice Chevallier, Jean Henri Bourhis, Jan J. Cornelissen, Henrik Sengeloev, Jürgen Finke, John A. Snowden, Tobias Gedde-Dahl, Jérôme Cornillon, Urs Schanz, Amit Patel, Linda Koster, Liesbeth C. de Wreede, Patrick Hayden, Kavita Raj, Joanna Drozd-Sokolowska, Carmelo Gurnari, Francesco Onida, Donal P. McLornan, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2024) 144 (4): 445–456.
https://doi.org/10.1182/blood.2023022273
Published: 2024
Includes: Supplemental data
Journal Articles

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee

Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe, Marie Robin, Argiris Symeonidis, Theo de Witte, Raphael Itzykson, Madlen Jentzsch, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Christof Scheid, Eric Solary, Peter Valent, Raffaela Greco, Isabel Sanchez-Ortega, Ibrahim Yakoub-Agha, Lisa Pleyer
Journal: Blood
Blood (2024) 143 (22): 2227–2244.
https://doi.org/10.1182/blood.2023023476
Published: 2024
Includes: Supplemental data
Journal Articles

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)

Clinical Trials & Observations
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Ronald Korn, Weixin Peng, Christine Lui, Jacob Wulff, Rhine Shen, Soumya Poddar, A. Scott Jung, Harry Miao, Sara Beygi, Caron A. Jacobson
Journal: Blood
Blood (2024) 143 (6): 496–506.
https://doi.org/10.1182/blood.2023021243
Published: 2024
Includes: Supplemental data
Journal Articles

A Retrospective Intra-Patient Analysis from ZUMA-5: Axicabtagene Ciloleucel (Axi-Cel) Compared with Prior Standard-of-Care Therapy in Patients with Relapsed/Refractory Follicular Lymphoma

Emmanuel Bachy, Sattva S. Neelapu, Julio C. Chavez, Ibrahim Yakoub-Agha, Christine Lui, Jacob Wulff, Harry Miao, Olga Nikolajeva, Timothy Best, Camille Linot, Caron A. Jacobson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4865.
https://doi.org/10.1182/blood-2023-175055
Published: 2023
Journal Articles

High Body Mass Index Is Associated with Favorable Outcome in Younger Patients Receiving CD19 CAR T-Cell Therapy for B-Cell Lymphoma: A Retrospective Study from the EBMT Transplant Complications Working Party

Christian R. Schultze-Florey, Christophe Peczynski, William Boreland, Michael Daskalakis, Anne Sirvent, Ibrahim Yakoub-Agha, Maria-Luisa Schubert, Christof Scheid, Anne Huynh, Victoria Potter, Didier Blaise, Matthew P. Collin, Sr., Rafael Hernani, Gerald G. Wulf, Francis A. Ayuk, Caroline Besley, Lucia Lopez Corral, Edouard Forcade, Peter Vandenberghe, Dominik Schneidawind, Matthias Stelljes, Friedrich Stölzel, Bertram Glass, Ivan Sergeevich Moiseev, Helene Schoemans, Olaf Penack, Christian Koenecke, Zinaida Peric
Journal: Blood
Blood (2023) 142 (Supplement 1): 4867.
https://doi.org/10.1182/blood-2023-187393
Published: 2023
Journal Articles

Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Noureddine Henoun Loukili, Luuk Gras, Sr., Linda Koster, Didier Blaise, Tobias Gedde-Dahl, Johan Maertens, Regis Peffault De Latour, Henrik Sengeloev, Stephan Mielke, Patrice Chevallier, Jakob R. Passweg, Jenny Louise Byrne, Urpu Salmenniemi, Anne Sirvent, Denis Guyotat, Simona Sica, Liesbeth C. de Wreede, Francesco Onida, Christoph Scheid, Carmelo Gurnari, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2023) 142 (Supplement 1): 472.
https://doi.org/10.1182/blood-2023-172796
Published: 2023
Journal Articles

HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party

Esteban Arrieta-Bolanos, Edouard F. Bonneville, Marie Robin, Tobias Gedde-Dahl, Urpu Salmenniemi, Nicolaus Kröger, Ibrahim Yakoub-Agha, Charles Crawley, Goda Choi, Annoek E. C. Broers, Edouard Forcade, Martin Carre, Xavier Poiré, Anne Huynh, Péter Reményi, Stig Lenhoff, Fabio Ciceri, Eleni Tholouli, Thomas Schröder, Eric Deconinck, Kristina Elisabet Carlson, Liesbeth C. de Wreede, Jorinde D. Hoogenboom, Florent Malard, Annalisa Ruggeri, Katharina Fleischhauer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2178.
https://doi.org/10.1182/blood-2023-185945
Published: 2023
Journal Articles

Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 4-Year Follow-up from the Phase 2 ZUMA-5 Trial

Sattva S. Neelapu, Julio C. Chavez, Alison R Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph D. Rosenblatt, Weixin Peng, Christine Lui, Jacob Wulff, Rhine R. Shen, Soumya Poddar, Andrew Lee, Harry Miao, Olga Nikolajeva, Caron A. Jacobson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4868.
https://doi.org/10.1182/blood-2023-174914
Published: 2023
Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Yishan Ye, Myriam Labopin, Gerard Socié, Ibrahim Yakoub-Agha, Igor Wolfgang Blau, Mahmoud Aljurf, Édouard Forcade, Tobias Gedde-Dahl, David Burns, Jan Vydra, Khaled Halahleh, Sr., Rose-Marie Hamladji, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Lin Li, Yi Luo, Yanmin Zhao, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin, Sr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 659.
https://doi.org/10.1182/blood-2023-186735
Published: 2023
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Jakob R. Passweg, Jennifer Clay, Sr., Jurgen Kuball, Alessandro Rambaldi, Patrick John Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsene Mekinian, Sinisa Savic, Maria Teresa Voso, Joanna Drozd-Sokolowska, John Snowden, Kavita Raj, Tobias Alexander, Marie Robin, Raffaella Greco, Donal P McLornan
Journal: Blood
Blood (2023) 142 (Supplement 1): 708.
https://doi.org/10.1182/blood-2023-174385
Published: 2023
Journal Articles

Outcome of Allogeneic Stem Cell Transplantation in FLT3-TKD-Mutated AML - a Study on Behalf of the Acute Leukemia Working Party of the EBMT

Thomas Heinicke, Myriam Labopin, Didier Blaise, Jaime Sanz, Ibrahim Yakoub-Agha, Thomas Cluzeau, Marco Ladetto, Jürgen Finke, Eric Deconinck, Jurjen Versluis, Urpu Salmenniemi, Andreas Neubauer, Eolia Brissot, Ali Bazarbachi, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4976.
https://doi.org/10.1182/blood-2023-174233
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelodysplastic Neoplasms Allografted with an Unrelated Donor: A Registry Study of the Chronic Malignancies Working Party of the EBMT

Yves Chalandon, Dirk-Jan Eikema, Sr., Ivan Sergeevich Moiseev, Fabio Ciceri, Linda Koster, Jan Vydra, Jakob R. Passweg, Montserrat Rovira, Mutlu Arat, Tobias Gedde-Dahl, Nicolaus Kröger, Victoria Potter, Ibrahim Yakoub-Agha, Alessandro Rambaldi, Maija Itäla-remes, Alina Daniela Tanase, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Donal P McLornan, Marie Robin
Journal: Blood
Blood (2023) 142 (Supplement 1): 898.
https://doi.org/10.1182/blood-2023-178287
Published: 2023
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry

Sarah Cayla, Benoit Ferment, Noemie Bigot, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Jerome Lambert, Thierry Facon, Herve Avet Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2023) 142 (Supplement 1): 2139.
https://doi.org/10.1182/blood-2023-188655
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT

Juan Montoro, Ariane Boumendil, Hervé Finel, Stefania Bramanti, Luca Castagna, Sr., Didier Blaise, Alida Dominietto, Aleksandr Kulagin, Sr., Ibrahim Yakoub-Agha, Abdelghani Tbakhi, Carlos Solano, Sebastian Giebel, Zafer Gulbas, Dolores Caballero, Jose A. Perez-Simon, Jose Luis Diez Martin, Paolo Corradini, Yener Koc, Gerard Socié, Mutlu Arat, Manuel Jurado, Arancha Bermudez, Hélène Labussière-Wallet, Marta Villalba, Fabio Ciceri, Montserrat Rovira, Arnon Nagler, Anna Maria Sureda Balari, Bertram Glass
Journal: Blood
Blood (2023) 142 (Supplement 1): 4975.
https://doi.org/10.1182/blood-2023-179829
Published: 2023
Journal Articles

Graft-Versus-Host Disease after Anti-CD19 Chimeric Antigen Receptor T-Cell Infusion Post Allogeneic Hematopoietic Cell Transplantation: A Transplant Complications and Paediatric Disease Working Parties EBMT Joint Study

Guillermo Orti, Christophe Peczynski, Christian Koenecke, William Boreland, Maeve O'Reilly, Martin Bornhäuser, Adriana Balduzzi, Caroline Besley, Krzysztof Kalwak, Samppa Ryhanen, Sr., Tayfun Güngör, Robert F. Wynn, Peter Bader, Stephan Mielke, Didier Blaise, Persis Amrolia, Ibrahim Yakoub-Agha, Friso G. J. Calkoen, Maria-Luisa Schubert, Victoria Potter, Wolfgang Holter, Nicolaus Kröger, Mi Kwon, Henrik Sengeloev, Helene Schoemans, Ivan Sergeevich Moiseev, Olaf Penack, Zinaida Peric
Journal: Blood
Blood (2023) 142 (Supplement 1): 2189.
https://doi.org/10.1182/blood-2023-177715
Published: 2023
Journal Articles

How Much Have Post-Transplant Outcomes Improved Since 2000 for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Remission? a Study from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, Myriam Labopin, Iman Abou Dalle, Ibrahim Yakoub-Agha, Regis Peffault De Latour, Thomas Schroeder, Didier Blaise, Xavier Poire, Marie Balsat, Urpu Salmenniemi, Nicolaus Kröger, Aleksandr Kulagin, Sr., Eva Wagner Drouet, Depei Wu, Eolia Brissot, Arnon Nagler, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 2234.
https://doi.org/10.1182/blood-2023-179578
Published: 2023
Journal Articles

UM171 Expanded Cord Blood Transplantation Outcomes Compare Favorably to All Different Stem Cell Sources: An EBMT Registry Case-Control Analysis

Sandra Cohen, Myriam Labopin, Nadia M. Bambace, Imran Ahmad, Maude Dumont-Lagacé, Fabio Ciceri, Donal P McLornan, Hélène Labussière-Wallet, Nicolaus Kröger, Regis Peffault De Latour, Yves Chalandon, Edouard Forcade, Thomas Cluzeau, Pavel Jindra, Aleksandr Kulagin, Sr., Jean Roy, Sylvie Lachance, Frederic Barabe, Pierre Caudrelier, Ibrahim Yakoub-Agha, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4977.
https://doi.org/10.1182/blood-2023-173727
Published: 2023
Journal Articles

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo G. Carrabba, Christian Chabannon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Roch Houot, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermín Sánchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A. Snowden, Catherine Thieblemont, Max Topp, Pier Luigi Zinzani, John G. Gribben, Chiara Bonini, Anna Sureda, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2023) 142 (10): 865–877.
https://doi.org/10.1182/blood.2023020578
Published: 2023
Includes: Supplemental data
Journal Articles

French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry

Benoit Ferment, Jérôme Lambert, Denis Caillot, Ingrid Lafon, Lionel Karlin, Anne Lazareth, Cyrille Touzeau, Xavier Leleu, Niels Moya, Stephanie Harel, Aurore Perrot, Pierre Bories, Laure Vincent, Sylvain Lamure, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Anne-Marie Stoppa, Gabriel Brisou, Olivier Decaux, Roch Houot, Steven Le Gouill, Thierry Facon, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood
Blood (2022) 140 (Supplement 1): 4668–4670.
https://doi.org/10.1182/blood-2022-162682
Published: 2022